School of Medicine Department of Obstetrics, Gynecology and
Reproductive Sciences--Division of Gynecologic Oncology
Pittsburgh, PA
The focus of Dr. Taylor’s clinical and translational research is in the development and implementation of early phase clinical trials. Her specific area of interest is in women with gynecologic malignancies. As a gynecologic oncologist, her primary role is to see and care for women with gynecologic malignancies, which gives Dr. Taylor expertise as well as knowledge of the daily challenges both patients and the physicians face when fighting these cancers. Dr. Taylor’s research is focused within the University of Pittsburgh Cancer Institute/UPMC Hillman Cancer Center’s (HCC) Phase I Translational Research Team, which is a multi-specialty group focused on the development, promotion and execution of novel phase I oncologic clinical trials.
Dr. Taylor’s work within the Magee-Womens Research Institute focuses on correlative biomarker development and identifying targetable pathways for drug development. Her collaborations extend to her colleagues within the Women’s Cancer Research Group at the University of Pittsburgh School of Nursing. As an interdisciplinary team of researchers, they focus on overlapping research interests regarding patients’ quality of life, health services research, and patient-reported outcomes. This ongoing work recognizes the importance of care the spans the life of a woman who lives with and survives cancer.
Dr. Taylor’s current research focus is on development and implementation of phase I and phase II clinical trials in the treatment of gynaecologic malignancies. The role of clinical trials in the development of novel approaches to cancer treatment extends beyond drug development. As such, Dr. Taylor has extended her research collaborations with the Women’s Cancer Research Group at the University of Pittsburgh School of Nursing.